HLA-G, as a non-classical major histocompatibility complex (MHC) class I molecule, often directly inhibited natural killer (NK) and tumor-specific T cells, and expressed in up to 34% EWS samples (Spurny et al., 2018). The gene discussed is HLA-G; the disease is neoplasm.